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Insulin-like growth factor 1 (IGF-1) is a powerful regulator of synaptic activity and a
deficit in this protein has a profound impact on neurotransmission, mostly on excitatory
synapses in both the developing and mature auditory system. Adult Igf1−/− mice
are animal models for the study of human syndromic deafness; they show altered
cochlear projection patterns into abnormally developed auditory neurons along with
impaired glutamate uptake in the cochlear nuclei, phenomena that probably reflect
disruptions in neuronal circuits. To determine the cellular mechanisms that might
be involved in regulating excitatory synaptic plasticity in 4-month-old Igf1−/− mice,
modifications to neuroglia, astroglial glutamate transporters (GLTs) and metabotropic
glutamate receptors (mGluRs) were assessed in the cochlear nuclei. The Igf1−/− mice
show significant decreases in IBA1 (an ionized calcium-binding adapter) and glial
fibrillary acidic protein (GFAP) mRNA expression and protein accumulation, as well
as dampened mGluR expression in conjunction with enhanced glutamate transporter
1 (GLT1) expression. By contrast, no differences were observed in the expression
of glutamate aspartate transporter (GLAST) between these Igf1−/− mice and their
heterozygous or wildtype littermates. These observations suggest that congenital IGF-1
deficiency may lead to alterations in microglia and astrocytes, an upregulation of GLT1,
and the downregulation of groups I, II and III mGluRs. Understanding the molecular,
biochemical and morphological mechanisms underlying neuronal plasticity in a mouse
model of hearing deficits will give us insight into new therapeutic strategies that could
help to maintain or even improve residual hearing when human deafness is related to
IGF-1 deficiency.
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INTRODUCTION
Gene knockout studies in mice have demonstrated that insulin-like growth factor 1 (IGF-1), a
growth promoting hormone, is essential for the proper functioning of the inner ear (Magariños
et al., 2012; Varela-Nieto et al., 2013; Yamahara et al., 2015). A loss of this factor causes significant
anomalies in the development of cochlear circuits during postnatal development, which impairs
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peripheral function in these animals (Camarero et al., 2001, 2002;
Cediel et al., 2006; Riquelme et al., 2010). Indeed, immature
patterns of cochlear innervation persist in postnatal day 20 (P20)
knockout mice and the spiral ganglion is abnormal, phenomena
that are associated with increased auditory thresholds between
the ages of 1–12 months and that ultimately result in
severe sensorineural deafness (Murillo-Cuesta et al., 2011).
Consequently, there is hypotrophy and hypoplasia in the
cochlear nucleus of adult Igf1−/− mice, which develops in
parallel with higher wave II amplitudes in auditory brainstem
responses (ABRs). The lack of IGF-1 also modifies excitatory
but not inhibitory synapses in the cochlear nuclei, evident as an
upregulation in the vesicular glutamate-transporter 1 (VGluT1;
Fuentes-Santamaría et al., 2016). This modulation involves
myocyte enhancer factor-2 (MEF2) transcription factors, which
are downregulated in the IGF-1-deficient cochlea and cochlear
nucleus, and that play a pivotal role in regulating excitatory
synapses (Flavell et al., 2006; Ruffle et al., 2006; Sanchez-Calderon
et al., 2010; Rashid et al., 2014).
Glia are closely associated with synapses and they are key
regulators of synaptic neurotransmission in the central nervous
system (CNS; Bacci et al., 1999; Hansson and Rönnbäck,
2003; Ullian et al., 2004; Slezak et al., 2006). In the healthy
brain, quiescent microglial cells are very dynamic, and they
act as sensors to maintain environmental homeostasis in the
CNS. Along with their well-established role as modulators of
brain inflammation, responsive microglia monitor neuronal
excitability and they regulate synapse formation, maturation
and pruning by secreting factors that affect synaptic responses
(Eroglu and Barres, 2010). Under pathological conditions, these
non-neuronal cells also represent the first line of defense in the
CNS, responding quickly to signals released by injured neurons
and by synapses, by modifying their structural appearance
and physiology (Wolf et al., 2017). Studies based on glia-free
culture of isolated cortex, retinal ganglion cells or spinal motor
neurons have revealed that astrocytes also contribute to the
formation, maturation and stability of synapses (Nakanishi
et al., 1994; Pfrieger and Barres, 1996; Ullian et al., 2001).
When extracellular glutamate levels increase, accumulation of
this neurotransmitter is avoided by the clearance of glutamate
from the synaptic cleft by excitatory amino acid transporters
(EAATs) on astrocytes, preventing excess receptor activation
and hence, glutamate excitotoxicity (Danbolt, 2001). These
non-neuronal cells express both the EAAT1/glutamate aspartate
transporter (GLAST) and EAAT2/GLT1 human/rodent carrier
subtypes, and although their expression is region-selective (Lehre
et al., 1995), GLT1 appears to be responsible for most of
the glutamate uptake at excitatory synapses (Rothstein, 1996;
Lehre and Danbolt, 1998). More specifically, GLAST and not
GLT1 is expressed strongly by inner supporting cells in the
developing and adult mouse cochlea (Furness and Lehre, 1997;
Furness and Lawton, 2003; Jin et al., 2011), and it is responsible
for glutamate removal at the synapse between inner hair cells
and Type I spiral ganglion neurons (Glowatzki et al., 2006).
Fibrocytes in the spiral ligament and spiral limbus also express
high levels of GLAST, suggesting that these cells also regulate
cochlear glutamate uptake (Furness et al., 2009). The fact that
GLAST-deficient mice accumulate glutamate in the perilymph
in response to acoustic overstimulation led to the proposal
that this carrier protects against noise-induced hearing loss
(Hakuba et al., 2000; Chen et al., 2010). Ultrastructural studies
in the mouse have also provided evidence that both Na+-
dependent glutamate transporters (GLTs) are expressed strongly
in the cochlear nucleus, where they might modulate synaptic
function (Josephson and Morest, 2003). GLT1 is also expressed
by primary auditory neurons and glial cells in the spiral ganglion
(Rebillard et al., 2003).
By competing for neurotransmitter binding and/or uptake,
GLTs also modify the activation state of receptor populations
at nearby synapses (Huang et al., 2004; Galik et al., 2008;
Benediktsson et al., 2012). As such, electrophysiological
recordings in acute hippocampal slices demonstrate that
selective pharmacologic inhibition of astrocyte GLTs modifies
the access of mGluRs to glutamate released at interneuron
synapses (Huang et al., 2004; Nicoletti et al., 2011). These
mGluRs are G-protein coupled receptors (GCPRs) that activate
multiple signaling pathways to drive slow neuronal excitation in
the brain (Niswender and Conn, 2010). Based on their specific
properties, these receptors have been divided into groups I
(mGluR1 and mGluR5), II (mGluR2 and mGluR3) and III
(mGluR4, mGluR6, mGluR7, mGluR8), each of which seems
to be involved in modulating cell excitability and synaptic
transmission (Ferraguti and Shigemoto, 2006). The expression
of mGluRs in the mammalian and avian auditory system has
been seen to vary depending on the specific nucleus and the cell
types they contain (Petralia et al., 2000; Lu, 2014). For example,
mGluR1 and mGluR2 mRNA and protein has been detected in
both the dorsal and ventral subdivisions of the cochlear nuclei,
most intensely in the dorsal cochlear nucleus (DCN) where they
seem to be located both pre- and post-synaptically (Bilak and
Morest, 1998; Petralia et al., 2000; Kemmer and Vater, 2001;
Nicholas and Hyson, 2004; Diaz et al., 2009; Martinez-Galan
et al., 2010; Carzoli and Hyson, 2011, 2014). However, there is
some controversy regarding the expression of the mGluR4 and
mGluR7 subunits, and little information is available about
mGluR3, mGluR5, mGluR6 and mGluR8 (Lu, 2014).
In the present study, we have assessed whether IGF-
1-dependent alterations in synaptic neurotransmission in
the cochlear nuclei involve glial cell dysfunction. Given
that neuroglia actively participates in regulating synaptic
transmission, the expression of ionized calcium-binding adaptor
1 (IBA1) and glial fibrillary acidic protein (GFAP) mRNA and
protein was evaluated in mice lacking the Igf1 gene as markers
of microglial and astrocytes, respectively. In addition, as the
activity of the glutamatergic system is impaired in Igf1−/−
mice, possible abnormalities in the expression of the astroglial
glutamate carriers (GLT1 and GLAST) and metabotropic
glutamate receptors (mGluR1–5) were also investigated.
MATERIALS AND METHODS
Mouse Handling and Genotyping
Mice heterozygous for the Igf1 gene (Igf1+/−) were maintained
on a hybrid MF1 and 129/sv genetic background to increase
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the survival of Igf1−/− animals (Liu et al., 1993). Igf1−/− mice
mortality before adulthood is high, although between 20%–30%
survived. Male and female Igf1−/−, Igf1+/− and Igf1+/+ mice
littermates were used in this study, aged 4 months (n = 24), and
they were genotyped as described previously (Sanchez-Calderon
et al., 2010). The mice were fed tap water and a standard diet, and
they were housed following recommendations of the Federation
of European Laboratory Animal Science Associations. Animal
experimentation was carried out in accordance with Spanish and
European legislation (RD 53/2013; EU directive 2010/63/EU),
and the protocols were approved by the Animal Care and Use
Committees of Spanish National Research Council (CSIC).
Cytoarchitecture of the Mouse Cochlear
Nuclei
The nomenclature used to define the cochlear nucleus complex
was based on previous studies in the mouse (Mugnaini et al.,
1980; Martin and Rickets, 1981; Lambert and Schwartz, 1982;
Webster and Trune, 1982). The criteria for the classification of
cochlear nucleus neurons were based on cell size, shape and
location within the nucleus. As in other mammals, the cochlear
nuclei can be divided into two major regions termed the DCN
and the ventral cochlear nucleus. The DCN is a laminated
structure composed of three layers; the superficial molecular
layer (ml, layer 1), the granule/fusiform cell layer (grl, layer 2)
and the deep layer or central region (cr, layer 3) of the nucleus.
The layer 1 is composed of small stellate cells, cartwheel cells,
granule cell axons and fusiform cell dendrites. The layer 2 is
made up of diverse neuron types including fusiform cells, also
known as pyramidal or principal cells, many granule cells and
cartwheel cells while the layer 3 contains mostly giant cells and
tuberculoventral cells. The ventral cochlear nucleus is further
divided by the cochlear nerve root into posteroventral cochlear
nucleus (PVCN) and anteroventral cochlear nucleus (AVCN)
subdivisions. According to their size and morphology, there are
threemain types of ventral cochlear nucleus neurons: (1) globular
and spherical bushy cells are mainly located in the AVCN;
(2) multipolar cells are present in both the AVCN and the PVCN;
and (3) octopus cells are found exclusively in the PVCN. The
cochlear granule cell domain is a continuous sheet of tightly
packed granule cells which covers the dorsal and ventral regions
of the ventral cochlear nucleus and the granule/fusiform layer
of the DCN. A lamina of these cells also extends medially and
ventrally to separate the DCN from the PVCN.
RNA Isolation and Reverse Transcription
Quantitative PCR
Mice were sacrificed by barbiturate overdose (Dolethalr,
40–90 mg/kg i/p), decapitated and a midline incision was
made in the skin of the head to flip it over the eyes and free
the skull. Next, a frontal bone cross-section in the skull in
front of the olfactory bulbs and a caudal cross-section by the
interparietal bone were made. Both sections were joined by a
longitudinal section along the sagittal suture, which facilitated
partial removal of the frontal and parietal bones and exposure
of the encephalon. To locate the cochlear nuclei, different
anatomical landmarks including the cerebellum, the inferior
cerebellar peduncle and the spinal trigeminal tract were used as
reference points (Franklin and Paxinos, 2013). After removal
of the overlying cerebellar flocculus, the dorsal and ventral
cochlear nuclei of Igf1+/+, Igf1+/− and Igf1−/− mice (at least
n = 3 per genotype) were dissected off the dorsolateral part
of the brainstem (Ryugo and Willard, 1985; Juiz et al., 2000;
Fuentes-Santamaria et al., 2005; Caminos et al., 2015). Tissue
samples were conveniently stabilized using RNAlaterr and
disrupted with a TissueLyser system. Total RNA was isolated
and genomic DNA efficiently removed using the RNeasy Plus
Mini Kitr automated on a QIAcube (QIAGEN), according to
manufacturer’s instructions. Quality and quantity of RNA was
further assessed by using the Agilent 2100 bioanalyzer, only
samples with a RIN > 8.5 were used. Using equal quantities of
this RNA from each individual mouse as a template, cDNAs
were generated by reverse transcription (RT: High-Capacity
cDNA Reverse Transcription Kit; Thermo Fisher Scientific) and
amplified by quantitative PCR (qPCR) in a 7900HT System
(ThermoFisher Scientific) as described previously (Fuentes-
Santamaría et al., 2016). TaqManr Gene Expression Assays1
(Life Technologies) were used to detect Iba1 (Mm00479862_g1),
Gfap (Mm01253033_m1), Glast (Mm00600697_m1), Glt1
(Mm00441457_m1), mGluR1 (Mm01187089_m1), mGluR2
(Mm01235831_m1), mGluR4 (Mm01306128_m1) and mGluR7
(Mm01189424_m1). All probes used span exon/exon boundaries
with the exception of Iba1 (Mm00479862_g1). Randomly,
control reactions were carried out to secure the quality of the
reagents used (no cDNA) and purity of RNA preparations
(no RT). Hypoxanthine phosphoribosyltransferase 1 (Hprt1)
and ribosomal protein lateral stalk subunit P0 (Rplp0) were
used as endogenous reference genes for normalization, and the
relative quantity (RQ) was calculated against calibrator samples,
as determined by the 2−∆∆Ct method (Livak and Schmittgen,
2001). The data are presented as the mean RQ.
Characterization of Primary Antibodies
Information about the primary antibodies used in this study
is summarized in Table 1. The anti- NeuN antibody was
produced from the nuclei of mouse brain cells and as described
previously (Mullen et al., 1992; Lind et al., 2005), it detects
a single 48 kDa band in western blots of mouse brain tissue.
It has been used as a neuronal maker as it recognizes the
neuron-specific NeuN protein, which is widely expressed in
peripheral and central neurons (Rasmussen et al., 2007). The
staining pattern described here for the cochlear nuclei matches
previous descriptions (Fuentes-Santamaría et al., 2012). The
anti-calretinin (CR) antibody was raised against the human CR
protein and its specificity has been assessed in Western blots
of membrane fractions from the cochlear nucleus, recognizing
a single specific 31 kDa band (Fuentes-Santamaria et al., 2005).
The IBA1 antibody was raised against a synthetic peptide
corresponding to the C-terminal fragment of rat protein,
N-PTGPPAKKAISELP-C (Imai et al., 1996). This antibody
recognizes a single band with an estimated molecular weight of
17 kDa, and it stainsmicroglia andmacrophages in the peripheral
1https://bioinfo.appliedbiosystems.com/genome-database/gene-expression.html
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TABLE 1 | List of primary antibodies.
Primary antibody Immunogen Host Code/clone Dilution Manufacturer
NeuN Recombinant mouse NeuN Guinea Pig ABN90 1:2,000 Millipore, Billerica, MA, USA
CR Recombinant human CR Rabbit 7699/3H 1:1,500 Swant, Bellinzona, Switzerland
Iba-1 C-terminus of Iba1′ (N′-PTGPPAKKAISELP-C′) Rabbit 019-19741 1:2,000 Wako Pure Chemical Industries, Neuss, Germany
GFAP Cow spinal cord GFAP Rabbit Z0334 1:2,000 Dako, Glostrup, Denmark
GLAST C-terminus of EAAT1 of human origin Goat SC-7757 1:100 Santa cruz Biotechnology, Inc. Germany
GLT-1 Carboxy-terminus of rat GLT-1 Guinea pig AB1783 1:200 Millipore, Billerica, MA, USA
mGluR1α Mouse mGluR1a, 945–11277aa Rabbit G046-mGluR1a-AG 1:1,000 Frontier Institute, Japan
and central auditory system (Ito et al., 1998; Sasaki et al., 2001;
Fuentes-Santamaría et al., 2012). The GFAP antibody was raised
against GFAP from bovine spinal cord and it recognizes a
single 50 kDa band in western blots that corresponds to the
GFAP protein (Debus et al., 1983). GFAP is an intermediate
filament protein and it mainly stains astrocytes in the mature
CNS. It is important to note that GFAP is a reliable marker
to label reactive protoplasmic and fibrous astrocytes but since
some resting astrocytes express this marker only weakly, they
might not be detected by immunohistochemistry (Sofroniew
and Vinters, 2010). GFAP staining in the mouse cochlear
nuclei with this antibody was consistent with previous studies
in rodents (Fuentes-Santamaría et al., 2017). The anti-EAAT1
(GLAST) antibody was raised against a peptide mapping to
the C-terminus of human EAAT1 and it detects a single band
at approximately 65 kDa in Western blots of rat brain tissue.
EAAT1 is an excitatory amino acid transporter expressed mainly
in astrocytes and staining of the mouse cochlear nucleus with
this antibody matched previous observations (Furuta et al., 1997;
Schmitt et al., 1997). The anti-EAAT2 (GLT1) antibody was
raised against a synthetic peptide from the carboxy-terminus
of rat GLT1 and its target is also an excitatory amino acid
transporter mainly located in astrocytes. Its specificity and
staining pattern have been described elsewhere (Furuta et al.,
1997; Atoji and Islam, 2009).
Immunohistochemistry
Under deep ketamine hydrochloride anesthesia (0.12 mg/g
injected i.p.—intraperitoneal), mice (n = 15) were transcardially
perfused with a 0.9% saline solution, followed by a solution of
4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB;
pH 7.3). The brain of the mice was removed and incubated
overnight in 30% sucrose in PB, and coronal sections (40 µm)
were then obtained on a sliding microtome. The brain tissue
from each genotype was processed simultaneously. The sections
were rinsed in Tris-buffered saline (TBS, pH 7.4) containing
0.2% Triton X-100 (Tx) and incubated overnight (with agitation)
at 4◦C with a primary antibody raised against IBA1, GFAP,
GLT1, GLAST or mGluR1α. After several rinses in TBS-Tx 0.2%,
antibody binding was detected over 2 h with the corresponding
biotinylated secondary antibodies (1:200; Vector Laboratories,
Burlingame, CA, USA), and the antigen-antibody complex was
visualized by incubating for 1 h in ABC reagent (PK-6100,
vector laboratories, Burlingame, CA, USA) at room temperature
and performing diaminobenzidine histochemistry. Finally, the
sections were mounted onto gelatin-coated slides, air-dried and
coverslipped using Cytoseal (Stephens Scientific, Camden, NJ,
USA) for light microscopy analysis. Control experiments were
performed by omitting either the primary or secondary antibody,
or the ABC reagent, resulting in no staining.
Double Immunofluorescence Labeling
An alternate set of brain sections from these same animals was
rinsed several times in PBS-Tx 0.2% and incubated overnight in
the corresponding cocktail of primary antibodies. Sections were
double-labeled with a solution containing primary antibodies
against IBA1and NeuN, GFAP and NeuN, GLAST and calretinin
(CR), or mGluR1α and NeuN, and single-labeled with GLT1
(Table 1). After four 15 min rinses in TBS-Tx (0.2%), the
secondary antibodies (1:200) were applied for 2 h at room
temperature: donkey anti-goat conjugated to Alexa 488 and
donkey anti-rabbit conjugated to Alexa 594 for GLAST and CR;
goat anti-rabbit conjugated to Alexa 488 and goat anti-guinea
pig conjugated to Alexa 594 for IBA1/NeuN, GFAP/NeuN
and mGluR1α/NeuN; goat anti-guinea pig conjugated to
Alexa 594 for GLT1 (Molecular Probes, Eugene, OR, USA).
These sections were then counterstained with DAPI (4′,6-
diamidino-2-phenylindole;Molecular Probes, Eugene, OR, USA)
and mounted.
Morphometric Analysis of Microglia
Branching: Skeleton Analysis
To evaluate the possible modifications in the ramification of
microglia in the cochlear nuclei due to IGF-1 deficiency, a
skeleton analysis was performed using NIH ImageJ software
(Schneider et al., 2012). The analysis of each nucleus was done
on four sections from three mice per genotype. Images were
captured with a 40× objective, converted into 16-bit scale and
by using the thresholding function, the immunostainedmicroglia
were counted using a cell counter plug-in. The 16-bit scale
images were then transformed into binary images that were
subsequently, skeletonized (Figure 1). The Analyze Skeleton
plug-in (version 3.1.32, Arganda-Carreras et al., 2010), was used
to calculate the endpoints and the processes length in each
field. The obtained values were normalized and expressed as
endpoints/cell and process length/cell (Morrison and Filosa,
2013; Turlejski et al., 2016; Morrison et al., 2017). The following
parameters were evaluated: (1) the number of microglial cells
per field; (2) the number of microglia process endpoints per
cell; and (3) the microglia process length per cell (µm). The
endpoints/cell give us an estimate of the number of branch
points of microglia, while the process length/cell gives us the
2https://imagej.net/AnalyzeSkeleton
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FIGURE 1 | Morphometric analysis of microglial branching. For the skeleton analysis, digital images of IBA1 immunostained cells were captured with a 40×
objective (A,E), converted into binary images (B,F) and then skeletonized (C,G). To evaluate microglial morphology parameters, skeletonized images were processed
using the Analyze Skeleton plugin for Image J. Each glial cell is identified with a different color. The representative glia is shown in purple, and part of the skeleton of
the other glial cells is shown in yellow, blue and white (D,H).
mean length of microglial branches (Morrison and Filosa, 2013;
Turlejski et al., 2016; Morrison et al., 2017). It is possible, at
least in some instances that, after generating the skeleton, a
few loops could be detected by the software in the resultant
images. For pruning these loops, the software compares the
original and the resulting skeleton images and by using, in
our case, the method of the lowest intensity voxel, it excludes
any voxel with intensities below the threshold. In that way,
any possible loop/s that could affect the measurement will be
eliminated. Similar to the densitometric analysis, and to avoid
bias, all measurements were performed by the same experimenter
blinded to the mouse genotype.
Evaluation and Quantification of the
Immunostaining
Light Microscopy
The brains that were processed for light microscopy were
analyzed with brightfield illumination using a Nikon Eclipse
photomicroscope equipped with a 40× objective. Images were
captured with a DXM 1200C digital camera attached to the
microscope. This study evaluates qualitatively and quantitatively
the immunostaining produced by different antibodies used to
label microglia, astrocytes, astroglial GLTs and mGluRs in
the mouse cochlear nuclei. The qualitative parameters used to
assess the immunostaining were: (1) cell morphology (ramified
vs. bipolar), staining intensity (weak, moderate, or strong)
and immunopositive profiles (cell/puncta) area. The quantitative
analysis was provided through the use of custom-made macros
that were written in a Pascal-like language (Xu et al., 2000;
Alvarado et al., 2004). Captured color images of each selected
field were digitized and the ensuing 8-bit images had a grayscale
of pixel intensities that ranged from 0 (white) to 255 (black).
Three animals of each genotype were used to evaluate the
immunostaining in the DCN, PVCN and AVCN. In each coronal
section, three microscopic fields (36.85 × 103 µm2; dorsal,
middle and ventral) were sampled 160 µm apart using a 40×
objective and a total of four sections per mouse were analyzed.
To quantify the immunostaining, images containing grayscale
values from 0 to 255 were normalized, and then, an automatic
threshold was set as two standard deviations above the value
of the field. Profiles exceeding the threshold for detection were
considered as labeled. The mean gray level of the immunostaining
and the immunostained area were used as indicators of the
protein levels and cell/puncta immunostained area, respectively
(Fuentes-Santamaria et al., 2005; Alvarado et al., 2007b, 2014;
Adams et al., 2008). The immunostained area gave us an estimate
of the area occupied by stained profiles and it was calculated as
the sum of all the immunostained cellular elements present in
the field (Benson et al., 1997; Fuentes-Santamaría et al., 2012,
2013). To avoid bias, all measurements were performed by the
same experimenter blinded to the animal conditions.
Confocal Microscopy
The brains from each genotype were processed simultaneously
and the cochlear nuclei photographed under similar conditions.
For appropriate image acquisition and interpretation, the
following parameters were controlled: laser intensity, detector
gain, pinhole aperture, number of optical sections and Z-
stacking. For each dye, optical sections every 2.5 µm through
the thickness of each nucleus were captured sequentially with
40× or 63× Plan Apo oil-immersion objectives, merged and
saved as TIFF files using the ZEN 2009 Light Edition software.
Fluorescent sections were examined with a laser scanning
confocal microscope (LSM 710: Zeiss, Germany) with excitation
laser lines at 405, 488 and 594 nm.
Image Processing and Statistical Analysis
Photoshop CS3 (Adobe) and Canvas X (Deneba) were used
to adjust the size, brightness and contrast of the images. The
immunohistochemical and qPCR data were expressed as the
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means ± SD, and the statistical comparisons among genotypes
were made using a one-factor analysis of variance and Scheffé’s
post hoc analysis as necessary. A p-value < 0.05 was considered
statistically significant, and the significance levels (α) and power
(β) were set to 0.05 and 95%, respectively. Significant differences
among animal groups are indicated by asterisks: ∗p < 0.05;
∗∗p< 0.01; and ∗∗∗p< 0.001.
RESULTS
Altered Microglial Morphology and
IBA1 Downregulation in Igf1−/− Mice
As alterations to microglia may lead to neuronal and
synaptic dysfunction (Kettenmann et al., 2013; Wu et al.,
2015), the morphology of these non-neuronal cells and their
IBA1 expression was studied in the cochlear nuclei of Igf1−/−
mice and compared to heterozygous and wild-type mice.
Regardless of the genotype, microglia in both cochlear nucleus
subdivisions had a resting phenotype, characterized by a
small round cell body with ramified processes (Figures 2, 3).
Qualitative observations showed that, when compared to the
other genotypes, Igf1−/− mice exhibited more lightly stained
microglia, which was coupled to an apparent decrease in both
cell number and microglia ramification in all the nuclei analyzed
(arrows in Figures 2C–E, 3E–G,K–M). To further assess the
branching of microglia, reconstructed Z-stack confocal images of
IBA1 stained microglia were also evaluated for each nucleus and
genotype (arrows in Figures 2F–H, 3H–J,N–Q). This analysis of
the confocal images also demonstrated that microglia in Igf1−/−
mice had shorter processes, which covered a smaller surface
area than in Igf1+/+ and Igf1+/− mice. These observations
were corroborated by analyses of variance (ANOVA), which
demonstrated a significant effect of IGF-1 deficiency over
the mean gray levels of IBA1 immunostaining in the DCN
(F(2,22) = 10.35, p < 0.001), PVCN (F(2,15) = 13.86, p < 0.001)
and AVCN (F(2,18) = 13.81, p < 0.001), as well as over the
immunostained areas in the DCN (F(2,22) = 10.77, p < 0.001),
PVCN (F(2,15) = 9.94, p < 0.01) and AVCN (F(2,18) = 12.15,
p < 0.001). Further analysis using a Scheffé’s post hoc test
FIGURE 2 | IBA1 immunostaining in the DCN of Igf1−/− mice. (A) Coronal section of a wild-type mouse brain taken from the Franklin and Paxinos (2013) mouse
brain atlas, to show the location of the DCN (red) and PVCN. (B) Representative coronal section of the cochlear nuclei in the wild-type genotype immunostained with
IBA1. In Igf1−/− mice, cells with multipolar or bipolar morphology were stained more weakly, and they had shorter processes than in Igf1+/+ and Igf1+/− mice
(arrows in C–E). The maximum intensity projections of confocal images of the DCN illustrate a reduction in microglial branching in Igf1−/− mice (arrow in H) when
compared to the other genotypes (arrows in F,G). Quantification of the immunostaining showed the significant decrease in the mean gray levels (I) and the
immunostained areas (J) in the Igf1−/− mouse when compared to the other genotypes. Arrows point to IBA1 immunostained cells. Cell nuclei in (F–H) are stained
with DAPI (blue). The error bars indicate the standard deviations of the mean. Statistically significant differences among the animal groups were evaluated by
one-factor analyses of variance (ANOVA; ∗p < 0.05; ∗∗p < 0.01). Abbreviations: Cb, Cerebellum; cr, central region of the dorsal cochlear nucleus (DCN); grl,
granule/fusiform layer; IBA1, ionized-calcium-binding adaptor; icp, inferior cerebellar peduncle; IRt, intermediate reticular nucleus; ml, molecular layer; NeuN,
neuronal marker; PVCN, posteroventral cochlear nucleus; sp5, spinal trigeminal nucleus; sp5OVL, spinal trigeminal nucleus, oral part, ventrolateral division; 4V, 4th
ventricle; 7N, facial nucleus. Scale bars: 250 µm in (B); 50 µm in (C; it also applies to C,D); 20 µm in (H; it also applies to F,G).
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FIGURE 3 | IBA1 immunostaining in the PVCN and AVCN of Igf1−/− mice.
(A,C) Coronal sections of a wild-type mouse brain, taken from Franklin and
Paxinos (2013) mouse brain atlas, showing the location of the PVCN (green)
and AVCN (blue). (B,D) Representative coronal sections of the ventral
cochlear nucleus in the wild-type genotype immunostained with IBA1. In the
PVCN and AVCN of Igf1−/− mice, there was less staining (G,J,M,P,Q) relative
to the Igf1+/+ (E,H,K,N) and Igf1+/− mice (F,I,L,O). Maximum intensity
projections of confocal images from the PVCN and AVCN show the reduced
microglial arborization in Igf1−/− mice as compared to the other genotypes
(H–J,N–Q for the PVCN and AVCN; respectively). Arrows point to
IBA1 immunostained cells. Cell nuclei are stained with DAPI (blue).
Abbreviations: AVCN, anteroventral cochlear nucleus; Cb, Cerebellum; IBA1,
ionized-calcium-binding adaptor; icp, inferior cerebellar peduncle; IRt,
intermediate reticular nucleus; NeuN, neuronal marker; PnC, pontine reticular
nucleus, caudal part; PVCN, posteroventral cochlear nucleus; sp5, spinal
trigeminal nucleus; sp5OVL, spinal trigeminal nucleus, oral part, ventrolateral
division; 4V, 4th ventricle; 7n, facial nerve; 7N, facial nucleus; 8n,
vestibulocochlear nerve. Scale bars: 250 µm in (D; it also applies to B);
50 µm in (F,J; it also applies to E,G,H,I); 20 µm in (L,O; it also applies to
K,M,N,P,Q).
determined that the mean gray levels in the Igf1−/− mice were
significantly lower than in the Igf1+/+ (p < 0.01 for the DCN,
p < 0.001 for the PVCN and AVCN) and Igf1+/− (p < 0.05 for
the DCN and AVCN, p < 0.01 for the PVCN) mice (Figures 2I,
4). Similar decreases were observed for the immunostained areas
relative to the Igf1+/+ (p < 0.01 for the DCN, p < 0.05 for
the PVCN and AVCN) and Igf1+/− (p < 0.01 for the DCN
and PVCN, p < 0.001 for the AVCN) mice (Figures 2J, 4).
Moreover, a one-way ANOVA analysis also identified an IGF-1
dependent effect on microglial ramification. Accordingly,
the morphometric analysis of microglial branching revealed
statistically significant decreases in the number of microglia/field
in the DCN, PVCN and AVCN of Igf1−/− mice compared to
Igf1+/+ and Igf1+/− mice, as well as in the microglia process
endpoints/cell and microglia process length/cell (Tables 2, 3;
also see Figure 1). In accordance with the immunohistochemical
data, qPCR gene expression studies detected weaker Iba1mRNA
expression levels in the cochlear nuclei of Igf1−/− mice relative
to the other genotypes (p< 0.05, Figure 4E).
Downregulation of GFAP Expression in
Igf1−/− Mice
Excitatory synaptic neurotransmission appears to be altered in
the cochlear nucleus of Igf1−/− mice (Fuentes-Santamaría et al.,
2016). Since astrocytes are modulators of mature and functional
synapses, and they are crucial for the maintenance of synapses
(Chung et al., 2006), the astrocytic expression of GFAP in
the cochlear nuclei was examined. In all genotypes evaluated,
GFAP protein was located in the cytoplasm and processes of
astrocytes that were highly ramified (Figures 5, 6). Specifically,
in the granule cell domain, immunostained astrocytes were
densely packed and intensely stained (asterisks in Figures 5A–C).
In agreement with previous observations in rodents (Burette
et al., 1998; Insausti et al., 1999), GFAP immunostaining in
the DCN of all genotypes, was distributed in a dorso-ventral
gradient, whereby the molecular layer was more intensely stained
than the intermediate granule/fusiform layer and the central
region of the DCN (insets in Figures 5A–C) where astrocytes
organized into patches characterized by multiple cells (arrows
in Figures 5A,B). In all of the mice analyzed, irrespective of the
genotype, astrocytes were associated with neurons in the cochlear
nucleus, as well as with other astrocytes (Figures 5D–F). In
IGF-1 deficient mouse, the immunostaining in the intermediate
and deep layers of the DCN, but not in the superficial layer
(ml), seemed to be weaker than in the other animal groups
(Figures 5A–F). Similarly, a reduction in the immunostaining
was also detected in the PVCN and AVCN of Igf1−/− mice
(Figures 5G–L, 6A–F). These decreases were confirmed by
ANOVA, which showed that there was a significant effect
of the IGF-1 deficiency on the mean gray levels of GFAP
immunostaining in the DCN (F(2,13) = 5.32, p < 0.05), PVCN
(F(2,18) = 17.32, p< 0.001) and AVCN (F(2,12) = 14.99, p< 0.001),
and on the immunostained areas in the DCN (F(2,13) = 17.88,
p < 0.001), PVCN (F(2,18) = 13.37, p < 0.001) and AVCN
(F(2,12) = 18.33, p< 0.001; Figures 5M–P, 6G,H). Similarly, there
was significantly less GfapmRNA in the Igf1−/− mice than in the
Igf1+/+ and Igf1+/− mice (p< 0.01, Figure 6I).
IGF-1 Dependent Alterations to Astrocyte
Glutamate Transporters
To determine possible abnormalities in astrocyte GLTs that
might contribute to abnormal excitatory synaptic activity in the
cochlear nucleus circuits of Igf1−/− mice, as reported previously
(Fuentes-Santamaría et al., 2016), the expression of GLT1 and
GLAST was investigated.
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TABLE 2 | Morphometric analysis of microglial ramification in the dorsal cochlear nucleus (DCN).
DCN
Genotype Microglia/field Microglia process endpoints/cell Microglia process length/cell (µm)
Igf1+/+ (1) 7.75 ± 0.48 45.00 ± 1.09 47.48 ± 1.08
Igf1+/− (2) 7.25 ± 0.25 46.23 ± 2.19 49.36 ± 2.79
Igf1−/− (3) 5.50 ± 0.29 38.22 ± 0.49 38.58 ± 1.69
F(2,9) = 11.67 (∗∗) 8.95 (∗∗) 8.43 (∗∗)
Statistical comparison Significance levels
1 vs. 2 NS NS NS
1 vs. 3 ∗∗ ∗ ∗
2 vs. 3 ∗ ∗∗ ∗∗
Values are means ± standard errors. Statistically significant differences among the animal groups were evaluated by one-factor analyses of variance (ANOVA; ∗p < 0.05; ∗∗ p < 0.01;
NS, No significant).
TABLE 3 | Morphometric analysis of microglial ramification in the posteroventral cochlear nucleus (PVCN) and anteroventral cochlear nucleus (AVCN).
PVCN
Genotype Microglia/field Microglia process endpoints/cell Microglia process length/cell (µm)
Igf1+/+ (1) 10.00 ± 0.41 52.36 ± 3.00 54.00 ± 3.98
Igf1+/− (2) 10.75 ± 0.63 46.94 ± 2.29 52.92 ± 1.79
Igf1−/− (3) 8.00 ± 0.41 40.67 ± 1.92 38.95 ± 2.85
F(2,9) = 8.31 (∗∗) 4.12 (∗) 4.94 (∗)
Statistical comparison Significance levels
1 vs. 2 NS NS NS
1 vs. 3 ∗ ∗ ∗
2 vs. 3 ∗∗ ∗ ∗
AVCN
Genotype Microglia/field Microglia process endpoints/cell Microglia process length/cell (µm)
Igf1+/+ (1) 10.75 ± 0.63 46.80 ± 1.13 49.38 ± 1.12
Igf1+/− (2) 10.50 ± 0.87 48.54 ± 2.30 51.83 ± 2.93
Igf1−/− (3) 7.50 ± 0.29 40.51 ± 0.52 40.49 ± 1.79
F(2,9) = 7.98 (∗∗) 7.81 (∗∗) 7.57 (∗∗)
Statistical comparison Significance levels
1 vs. 2 NS NS NS
1 vs. 3 ∗∗ ∗ ∗
2 vs. 3 ∗ ∗∗ ∗∗
Values are means ± standard errors. Statistically significant differences among the animal groups were evaluated by one-factor ANOVA (∗p < 0.05; ∗∗p < 0.01; NS, No significant).
Upregulation of EAAT2/GLT1 Expression in Igf1−/−
Mice
Regardless of the genotype, GLT1 immunostaining was evident
as dense punctate labeling that was similarly distributed
throughout the cochlear nuclei (Figures 7, 8). In the DCN,
the GLT1 stained puncta were distributed throughout the
molecular layer, granule/fusiform layer and the central region
of the DCN (Figures 7A–C). Similar diffuse punctate neuropil
staining was also observed in the PVCN (Figures 8A–C)
and AVCN (Figures 8F–H). Although the distribution of
GLT1 immunostaining was similar in the different genotypes,
the GLT1 puncta in Igf1−/− mice were apparently more strongly
stained and they seemed to occupy a larger extension in both
subdivisions of the cochlear nucleus (Figures 7, 8). These
qualitative immunohistochemical appreciations were confirmed
by ANOVA, which showed a significant effect of the absence
of IGF-1 on the mean gray level of GLT1 in the DCN
(F(2,10) = 15.94, p < 0.001), PVCN (F(2,10) = 61.48, p < 0.001)
and AVCN (F(2,9) = 32.92, p < 0.001) and also on the
immunostained areas in the DCN (F(2,10) = 28.16, p < 0.001),
PVCN (F(2,10) = 41.85, p < 0.001) and AVCN (F(2,9) = 28.66,
p < 0.001). As demonstrated using Scheffé’s post hoc test, the
mean gray levels in the Igf1−/− mice were significantly higher
than in the Igf1+/+ (p< 0.001 for DCN, PVCN and AVCN) and
Igf1+/− (p < 0.01 for DCN and AVCN, p < 0.001 for PVCN)
mice (Figures 7D, 8D,I). Likewise, the GLT1 immunostained
areas were also larger in the Igf1−/− mice than in the Igf1+/+
(p < 0.001 for all nuclei) and Igf1+/− (p < 0.001 for
DCN and PVCN; p < 0.01 for AVCN) mice (Figures 7E,
8E,J). Corroborating the protein expression data, Glt1 mRNA
expression in the Igf1−/− mice cochlear nuclei was significantly
stronger than in the other genotypes (p< 0.001; Figure 7F).
GLAST Expression in Igf1−/− Mice
Like GLT1, a dense network of GLAST immunostained puncta
was evident in the neuropil and around the soma of DCN,
PVCN and AVCN neurons in Igf1+/+, Igf1+/− and Igf1−/−
mice (Figure 9). However, in contrast to GLT1 there appeared
to be no significant differences in the immunostaining among
the distinct mouse genotypes, in either the mean gray levels of
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FIGURE 4 | Insulin-like growth factor 1 (IGF-1) deficiency leads to Iba1 downregulation in Igf1−/− mice. Bar graphs showing decreases in the mean gray levels (A,B)
and immunostained areas (C,D) in the Igf1−/− mouse cochlear nuclei when compared to Igf1+/+ and Igf1+/− mice. Similar reductions in Iba1 expression were also
detected by RT-quantitative PCR (qPCR; E). Error bars indicate the standard deviations of the mean. Statistically significant differences among the animal groups
were evaluated by one-factor ANOVA (∗p < 0.05; ∗∗p < 0.01, ∗∗∗p < 0.001). Abbreviations: AVCN, anteroventral cochlear nucleus; PVCN, posteroventral cochlear
nucleus.
GLAST immunostaining in the DCN (F(2,7) = 0.94, NS), PVCN
(F(2,9) = 1.01, NS) and AVCN (F(2,11) = 1.56, NS) or in the
immunostained areas in the DCN (F(2,7) = 0.24, NS), PVCN
(F(2,9) = 1.56, NS) and AVCN (F(2,11) = 0.93, NS; Figure 10).
In accordance with these immunohistochemical findings, there
were also no differences in Glast gene expression in the cochlear
nuclei of Igf1−/− mice relative to the Igf1+/− and Igf1−/−
mice (Figure 9J).
Downregulation of mGluRs in Igf1−/− Mice
As the upregulated GLT1 expression is suggestive of abnormal
glutamate uptake, the mRNA and protein expression of mGluRs
were also examined in the Igf1−/− mice cochlear nuclei. As
mGluR1α is expressed abundantly in the cochlear nuclei (Lu,
2014), its expression was evaluated at both the mRNA and
protein levels, whereas the expression of mGluR2, mGluR4 and
mGluR7 was only based on qPCR analyses. mGluR1α staining
was detected in the DCN of Igf1+/+, Igf1+/− and Igf1−/−
mice, mostly in the neuropil of the molecular layer and
on the dendrites of fusiform and cartwheel cells in the
granule/fusiform layer (Figures 11A–C), (Bilak and Morest,
1998; Petralia et al., 2000). Regardless of the genotype, the
immunostaining in the PVCN and AVCN was observed in
globular and stellate cells which were identified according
to their location within the nucleus, as shown previously
(Bilak and Morest, 1998; Figures 11D–I). In Igf1−/− mice, the
mGluR1α staining levels in the dorsal and ventral cochlear
nucleus subdivisions were weaker than in the other genotypes
(Figure 11). When quantified, immunostaining revealed a
significant effect of the lack of IGF-1 on the mean gray
level of mGluR1α in the DCN (F(2,13) = 18.17, p < 0.001),
PVCN (F(2,14) = 51.59, p < 0.001) and AVCN (F(2,9) = 56.55,
p < 0.001) and also on the immunostained areas in the
DCN (F(2,13) = 18.17, p < 0.001), PVCN (F(2,14) = 16.03,
p < 0.01) and AVCN (F(2,9) = 19.91, p < 0.001). According
to the post hoc test, the mean gray levels in the Igf1−/− mice
were significantly lower than in the Igf1+/+ (p < 0.01 for
the DCN, p < 0.001 for the PVCN and AVCN) and Igf1+/−
(p < 0.001 for all nuclei) mice (Figures 11J,L,N). Likewise,
the immunostained areas of mGluR1α were also smaller in
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FIGURE 5 | GFAP immunostaining in the DCN and PVCN of Igf1−/− mice. GFAP immunostaining was distributed throughout the different DCN layers in all the
genotypes analyzed (A–F). GFAP-immunostained astrocytes were strongly stained in the molecular layer while only a few astrocytes were observed in the
intermediate layer and central region of the DCN (A–C). Note that some of these astrocytes group together forming patches of immunostaining (arrows in A,B). In the
Igf1−/− mice, GFAP immunostaining was apparently weaker in the deeper layers (grl and cr) of the DCN and in the PVCN than in Igf1+/+ and Igf1+/− mice
(A–C,G–I). The spatial relationship between neurons and astrocytes in all genotypes is shown in Z-stack confocal microscopy images of the DCN (D–F) and PVCN
(J–L). Quantification of the mean gray levels (M,O) and stained areas (N,P) in these nuclei corroborated the decreases in the immunostaining. Asterisks in (A–C)
indicate GFAP immunostaining in the granule cell domain. Statistically significant differences among the mouse genotypes were evaluated by one-factor ANOVA
(∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). Cell nuclei in (D–F) and (J–L) are stained with DAPI (blue). The square boxes in (A–C) indicate the location of the higher
magnification images shown in (A–C; insets). Abbreviations: cr, central region of the dorsal cochlear nucleus (DCN); GFAP, glial fibrillary acidic protein; grl,
granule/fusiform layer; ml, molecular layer; NeuN, neuronal marker; PVCN, posteroventral cochlear nucleus; sp5, spinal trigeminal nucleus. Scale bars: 500 µm in (C;
it also applies to A,B); 100 µm in the inset in (C; it also applies to insets in A,B); 20 µm in (F,I; it also applies to D,E,G,H) and 50 µm in (L; it also applies to J,K).
the Igf1−/− mice than in the Igf1+/+ (p < 0.001 for the
DCN, p < 0.01 for the PVCN and AVCN) and Igf1+/−
(p < 0.01 for all nuclei) mice (Figures 11K,M,O). Significant
decreases in mGluR1, mGluR2 and mGluR4 gene expression
were detected in the Igf1−/− mouse cochlear nucleus relative
to the wild-type mice. Although mGluR7 expression also
appeared to be weaker, this difference did not reach statistical
significance (Figure 12).
DISCUSSION
The present study demonstrates that IGF-1 deficiency leads
to alterations in glial morphology, a decreased expression and
protein accumulation in IBA1 and GFAP, an upregulation of
GLT1 but not GLAST, and the downregulation of groups I, II and
III mGluRs. Our previous findings in Igf1−/−mice demonstrated
that primary cochlear afferents upregulate their VGluT1 protein
but not the vesicular GABA transporter (VGAT), suggesting
that presynaptic excitatory neurotransmission may be impaired.
This synaptic plasticity might be mediated by MEF2 proteins,
which are downregulated in both the cochlea and the cochlear
nucleus, and which may reflect enhanced synaptic efficacy
(Fuentes-Santamaría et al., 2016). As an activity-dependent
factor, rapid elevations of IGF-1 within neurons in response
to modifications in cochlear activity have been associated with
synaptic rearrangements in the rat cochlear nucleus (Alvarado
et al., 2007a; Fuentes-Santamaría et al., 2007, 2012, 2013). In
other brain structures like the hippocampus, IGF-1 is also a
regulator of excitatory synaptic transmission (Ramsey et al.,
2005; Xing et al., 2007; Deak and Sonntag, 2012). Indeed,
the effects of a reduced density of glutamatergic terminals
in the hippocampus of mice with low-serum IGF-1 levels
is ameliorated by continued systemic IGF-1 administration
(Trejo et al., 2007).
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FIGURE 6 | GFAP immunostaining in the AVCN of Igf1−/− mice. Analysis of GFAP immunostaining in the Igf1−/− mice showed that there were fewer astrocytes and
they were less intensely stained (C,F) when compared to Igf1+/+ (A,D) and Igf1+/− mice (B,E). Z-stack confocal microscopy images of GFAP and NeuN
double-labeling are shown for all genotypes (D–F). The apparent decrease in GFAP immunostaining in the Igf1−/− mouse was corroborated by quantifying the mean
gray levels (G) and the stained areas (H). The qualitative and quantitative data were confirmed when RT-qPCR data showed decreased Gfap expression in the
Igf1−/− mouse cochlear nuclei (I). The error bars indicate the standard deviations of the mean. Statistically significant differences among the animal groups were
evaluated by one-factor ANOVA (∗∗p < 0.01, ∗∗∗p < 0.001). Cell nuclei are stained with DAPI (blue). The square boxes in a-c indicate the location of the higher
magnification images shown in (A–C; insets). Abbreviations: AVCN, anteroventral cochlear nucleus; GFAP, glial fibrillary acidic protein; NeuN, neuronal marker; sp5,
spinal trigeminal nucleus. Scale bars: 500 µm in (C; it also applies to A,B); 100 µm in the inset in (C; it also applies to insets in A,B) and 20 µm in (F; it also
applies to D,E).
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FIGURE 7 | Upregulation of GLT1 in the DCN of Igf1−/− mice. In the Igf1−/− mouse, the strongly GLT1 immunostained puncta (red) were found in all layers of the
nucleus and presumptively occupied a larger area (C) than in the other genotypes (A,B). These qualitative observations were corroborated by significant increases in
the mean gray levels and the immunostained areas (D,E). Similar increases in the IGF-1 deficient DCN were also detected by quantifying Glt1 mRNA expression (F).
The inset in (A; pseudo-colored green for higher contrast) indicates the approximate location of the fields shown in (A–C). Error bars indicate the standard deviations
of the mean. Statistically significant differences among the animal groups were evaluated by one-factor ANOVA (∗∗p < 0.01, ∗∗∗p < 0.001). Cell nuclei are stained
with DAPI (blue). Abbreviations: cr, central region of the dorsal cochlear nucleus (DCN); GLT1, glutamate transporter 1; grl, granule/fusiform layer; ml, molecular layer.
Scale bar: 20 µm in (C; it also applies to A,B).
The effects of IGF-1 on glial cells have been studied in
different systems. When non-astrocytic inner retinal glia-like
cells are stimulated by IGF-1 in the avian retina, retinal neurons
and Müller glia are more vulnerable to excitotoxic damage
(Fischer et al., 2010). In the mouse retina, IGF-1 deficiency
causes age-associated retinal gliosis (Arroba et al., 2018). In
cerebellar cultures, blocking the IGF-1 receptor in astrocytes
reduces their capacity to rescue neurons damaged by oxidative
stress, suggesting that this growth factor is crucial for these
non-neuronal cells to exert their protective effects (Genis et al.,
2014). Moreover, transgenic mice overexpressing IGF-1 in the
retina develop gliosis and microgliosis, along with impaired
glutamate recycling, which leads to cell death. Hence, glial cells
appear to be involved in the regulation of excitatory synaptic
function (Villacampa et al., 2013). Our data demonstrate that
Igf1−/− mice have less Iba1 mRNA and, consequently, lower
IBA1 protein levels along with decreases in the mean gray levels
of IBA1 immunostaining and immunostained areas in both
cochlear nucleus subdivisions. Igf1−/− mice display structural
modifications of microglia including decreases in the number
of cells per field, shorter processes length and a reduction
in microglial branching as compared to heterozygous and
wildtype mice. The contribution of microglia to the adaptive
responses that take place in the auditory nuclei in response
to cochlear damage induced by acoustic trauma or cochlear
ablation has been well documented (Fuentes-Santamaría et al.,
2012; Dinh et al., 2014; Janz and Illing, 2014; Baizer et al.,
2015). In this regard, lesion-induced microglial activation
may exert regulatory influences on cochlear nucleus synapses,
contributing to structural and functional remodeling. Recent
data from microglia depletion models indicated that the loss
of microglia during brain development leads to defective
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FIGURE 8 | Upregulation of GLT1 in the ventral cochlear nuclei of Igf1−/− mice. Z-stack confocal microscopy images show enhanced GLT1 immunostaining (red) in
the IGF-1 deficient ventral cochlear nucleus (C,H) relative to the Igf1+/+ (A,F) and Igf1+/− mice (B,G). Quantification of the immunostaining confirmed this
upregulation in both the PVCN (D,E) and AVCN (I,J). The inset in (A,F; pseudo-colored green for higher contrast) indicates the approximate location of the fields
shown in (A–C,F–H); for the PVCN and AVCN, respectively. The error bars indicate the standard deviations of the mean. Statistically significant differences among
the animal groups were evaluated by one-factor ANOVA (∗∗p < 0.01, ∗∗∗p < 0.001). Cell nuclei are stained with DAPI (blue). Abbreviations: AVCN, anteroventral
cochlear nucleus; GLT1, glutamate transporter 1; PVCN, posteroventral cochlear nucleus. Scale bar: 20 µm in (C,H; it also applies to A,B,F,G).
glial-synapse communication and aberrant synaptic maturation
(Paolicelli and Ferretti, 2017). Indeed, the absence of IGF-1
leads to an ineffective refinement of cochlear synapses during
postnatal maturation, which results in dysfunctional excitatory
connections in the adult cochlear nucleus (Camarero et al., 2001;
Riquelme et al., 2010; Fuentes-Santamaría et al., 2016). Given that
microglial motility is primarily involved in reshaping neuronal
circuits during development, and in supporting and maintaining
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FIGURE 9 | Glutamate aspartate transporter (GLAST) immunostaining in the Igf1−/− mice cochlear nuclei. In all genotypes, GLAST stained puncta (green) were
densely distributed throughout the neuropil and on the soma of DCN (A–C), PVCN (D–F) and AVCN (G–I) neurons immunostained with CR (red). No differences
were observed in the distribution of the immunostaining among the three groups. The analysis of Glast expression levels by RT-qPCR confirmed these
immunohistochemical results (J). The error bars indicate the standard deviations of the mean. Arrows point to CR-immunostained cells. Cell nuclei are stained with
DAPI (blue). Abbreviations: AVCN, anteroventral cochlear nucleus; cr, central region of the DCN (dorsal cochlear nucleus); CR, calretinin; GLAST, glutamate aspartate
transporter; grl, granule/fusiform layer; ml, molecular layer; PVCN, posteroventral cochlear nucleus. Scale bar: 20 µm in (I; it also applies to A–H).
active synapses in the adult brain, limited microglial branching
due to IGF-1 deficiency may produce defective neuronal-
glial communication and consequently, abnormal synaptic
transmission in auditory nuclei.
Astrocytes continuously exchange signals with pre- and
postsynaptic elements at the tripartite synapse, and they are
also crucial for the formation and maintenance of glutamatergic
synapses due to their dynamic involvement in the processing
and integration of synaptic information (Ricci et al., 2009;
Villalba and Smith, 2011; Kim et al., 2017; Papouin et al., 2017).
Our data in the Igf1−/− mouse reveal a significant decrease in
GFAP protein and mRNA, as well as reductions in astrocyte
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FIGURE 10 | Histograms showing the mean gray levels of GLAST immunostaining and the immunostained areas in the cochlear nuclei of Igf1−/−, Igf1+/− and
Igf1+/+ mice. Analysis of the immunostaining indicated that there were no significant differences among the genotypes in either the mean gray levels of
immunostaining (A–C) or in the immunostained areas (D–F) in the DCN, PVCN and AVCN. The error bars indicate the standard deviations of the mean.
Abbreviations: DCN, dorsal cochlear nucleus; PVCN, posteroventral cochlear nucleus; AVCN, anteroventral cochlear nucleus.
FIGURE 11 | Downregulation of mGluR1α in the cochlear nuclei of Igf1−/− mice. In the Igf1−/− mice, there was less mGluR1α staining (green) in the molecular and
granule layers of the DCN than in the other genotypes (A–C). Similar decreases were also detected in Igf1−/− mouse PVCN (D–F) and AVCN (G–I). Quantification
confirmed these qualitative decreases in the Igf1−/− mouse relative to the Igf1+/+ and Igf1+/− mice (J–O). The error bars indicate the standard deviations of the
mean. Statistically significant differences among the animal groups were evaluated by one-factor ANOVA (∗∗p < 0.01, ∗∗∗p < 0.001). Neurons are stained with NeuN
antibody (red) and cell nuclei are stained with DAPI (blue). Abbreviations: AVCN, anteroventral cochlear nucleus; cr, central region of the dorsal cochlear nucleus
(DCN); grl, granule/fusiform layer; ml, molecular layer; mGluR1, metabotropic glutamate receptor 1; NeuN, neuronal marker; PVCN, posteroventral cochlear nucleus.
Scale bar: 20 µm in (I; it also applies to A–H).
density. In this regard, the loss of GFAP in Igf1−/− mice
results in increased synaptic plasticity and altered GLT activity,
suggesting that GFAP expression is essential to correctly regulate
glutamatergic neurotransmission (Hughes et al., 2004). It is
worth noting that the morphological and functional plasticity
of the astrocyte is achieved through polymerization/assembly
and depolymerization/disassembling of GFAP which acts a
scaffolding network for the translocation of GFAP-associated
functional molecules (Wang and Parpura, 2018), such as the
GLTs. Accordingly, it has been proposed that the glutamate-
mediated localization of GLT1 and GLAST in the astrocyte
membrane is highly dependent on the actin cytoskeleton of this
glial cell (Duan et al., 1999; Zhou, 2004). Astrocyte dysfunction
may modify the coverage of neurons by glia, increasing neuronal
communication and influencing glutamate concentrations and
therefore, the activity of carriers and receptors. GLT1 andGLAST
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FIGURE 12 | The loss of IGF-1 leads to mGluR1α, mGluR2α, mGluR4α and mGluR7α downregulation. The mGluR1α, mGluR2α, mGluR4α and mGluR7α mRNA
expression was determined by RT-qPCR in 4-month-old Igf1−/−, Igf1+/− and Igf1+/+ mice. The results demonstrate a decline in mGluR1α (A), mGluR2α (B),
mGluR4α (C) and mGluR7α (D) expression in the Igf1−/− mouse when compared with Igf1+/− and Igf1+/+ mice. Note that the decrease in mgluR7α expression in
the Igf1−/− mice was not statistically significant. Also, they show a significant downregulation of mGluR1α (A), mGluR2α (B) and mGluR4α in heterozygous mice
compared with their age-matched control mice. The error bars indicate the standard deviations of the mean. Statistically significant differences among the animal
groups were evaluated by one-factor ANOVA (∗p < 0.05; ∗∗p < 0.01, ∗∗∗p < 0.001).
are both high-affinity, sodium-dependent GLTs located on
perisynaptic processes of astrocytes and closely associated with
excitatory synapses. In cultures of chick cerebellar Bergmann glia
cells, GLT1 activity is modulated by IGF-1 signaling (Gamboa
and Ortega, 2002) and thus, the absence of this factor may alter
excitatory signaling.
GLT1 dysfunction has been linked to several neurological
disorders in which glutamate homeostasis is impaired
(Verkhratsky et al., 2012; Soni et al., 2014). For instance,
upregulation of GLT1 expression improves signs of Huntington’s
disease in symptomatic R6/2 mice (Miller et al., 2008) and
enhanced GLT1 expression also has been detected in the
prefrontal cortex of schizophrenic patients, suggesting impaired
glutamatergic transmission in this disease (Matute et al., 2005).
GLT1 also appears to be upregulated in Igf1−/− mice, the
predominant glial GLT, while the expression and accumulation
of the GLAST protein were not modified. In line with these
observations, GLT1 immunoreactivity is enhanced in cerebellar
synaptosomal preparations of Gfap−/− mice when compared
to wild-type animals (Hughes et al., 2004). Such upregulation
in cerebellar synaptic GLT1 protein expression may facilitate
the rapid uptake of synaptic glutamate through the activation
of mGluRs, suggesting a pivotal role for GFAP in trafficking
GLTs. Based on these observations, our results provide evidence
of IGF-1-dependent regulation of astrocytes, that alters glial
glutamate transport capacity and therefore, excitatory synapses.
Although the number of astrocytes and/or transporters per
cell was not assessed for each genotype in the current study, it
is plausible to postulate that an upregulation in GLT1 in the
mutant mouse would contribute to clear excessive glutamate
resultant from increased neuronal interactions in response to
astrocytes loss and/or dysfunction. Indeed, GLT1 is responsible
for most of the glutamate uptake (90%) around excitatory
synapses (Lehre and Danbolt, 1998), although the mechanisms
that drive the increase in GLT1 in the Igf1−/− mice are
still unclear.
GLT1 overexpression near synapses could have important
consequences for the kinetics of glutamate uptake and hence,
on mGluR levels in the cochlear nuclei. For instance, an
upregulation in GLT1 in the Igf1−/− cochlear nuclei will
reduce the amount of glutamate available in the synaptic
cleft, thus resulting in decreased glutamate binding to mGluRs
(Huang et al., 2004). This decrease, in turn, would lead to
significantly dampen the gene expression levels of mGluR1,
mGluR2, mGluR4 and mGluR7, as demonstrated in this study.
In accordance with our data, previous studies have demonstrated
that mGluR1 is detected in the DCN of rodents under normal
physiological conditions, particularly on unipolar brush cells
and cartwheel cells, and also in globular bushy cells and
stellate cells in the PVCN and AVCN (Bilak and Morest,
1998; Kemmer and Vater, 2001). Although the mGluR1 in
the cochlear nuclei is mostly found post-synaptically, it has
also been detected in presynaptic elements (Petralia et al.,
1996; Wright et al., 1996). mGluR2 is also expressed in
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the cochlear nuclei while the expression of mGluR4 and
mGluR7 remains unclear (Lu, 2014). In vivo and in vitro
studies in the chick cochlear nucleus, nucleus magnocellularis,
have demonstrated that pharmacological blockade of groups
I and II mGluR activation provokes neuronal degeneration,
suggesting a pivotal role for these receptors in regulating
neuronal survival (Nicholas and Hyson, 2004; Diaz et al.,
2009; Carzoli and Hyson, 2011, 2014). The activation of these
receptors also regulates glutamate uptake at the cochlear nucleus-
auditory nerve synapse, preventing the excitotoxic accumulation
of extracellular glutamate (Carzoli and Hyson, 2014). Whole
cell recordings in brain slice preparations demonstrated that
the activity of mGluRs suppresses GABAergic transmission (Lu,
2007), highlighting their role in achieving balanced excitation
and inhibition in the nucleus magnocellularis.
In summary, adult Igf1−/− mice show modifications in
the morphological features of the glutamatergic synapses
(presynaptic and postsynaptic components) that lead to
excitatory synaptic plasticity, which involves not only auditory
neurons but also glial cells. Although the role of microglia in
this process is unclear, their reduced arborization may result in
more prolonged microglia response times and therefore, lead
to decreased modulation of neuronal activity. On the other
hand, the reduction in the fine astrocytic processes may facilitate
neuronal interactions that, along with an enhanced expression
of GLT1, would contribute to regulation of synaptic glutamate
resulting from excessive neuronal activation.
CONCLUSION
The results presented here suggest that absence of IGF-1 leads
to central adaptive events in the adult Igf1−/− cochlear nuclei,
which include structural impairment of microglia and astrocytes,
upregulation in GLT1 expression, and downregulation of
mGluRs. These morphological alterations may contribute to
adaptation of auditory neurons and their synaptic connections
to changing levels of activity, due to the imbalances in
neurotransmission. Determining the molecular, biochemical and
morphological mechanisms underlying neuronal plasticity in
a mouse model of hearing deficits will give us insight into
new therapeutic strategies that could help to maintain or even
improve residual hearing when human deafness is related to
IGF-1 deficiency.
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